Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
spacer.gif (43 bytes)
SafetyAlerts
April 21, 2000

Genentech, Inc. Recalls Certain Lots of Pulmozyme Inhalation Solution

Berlin, PA (SafetyAlerts) - Genentech, Inc. is conducting a voluntary Class II Drug Recall, withdrawing specified lots of Pulmozyme (dornase alfa, recombinant) Inhalation solution, due to a potential packaging defect which could result in ampule leakage. This action will bring closure to the process that was initiated with the Genentech Important Drug Notification issued March 13, 2000.

This product withdrawal is limited to the distributor and sub-distributor levels only, including chain distribution centers and pharmacies. With the knowledge of the US Food and Drug Administration, Genentech is now taking this action, as there has been adequate time for new product to fill the distribution pipeline.

This product withdrawal does not include notification and product return at the patient level.

Genentech requests that distribution centers and pharmacies take the following action steps:

1) This is a lot specific withdrawal. Please examine your stock immediately to determine if you have Pulmozyme inventory NDC# 50242-0100-40 of the lots listed on Attachment #1 only.

2) If so, discontinue distribution of those lots, complete the Returned Goods Packing Form provided, enclose it with your returned goods shipment, and affix the pre-addressed Return Label to the package.

3) Return using Federal Express.  Check X Bill to Recipient in the payment section and return 2-day Service to:

    Genentech, Inc.
    Attn: Materials Control Receiving
    437 Kaufmann Court
    South San Francisco, CA 94080

    Genentech will issue a credit through your wholesaler at the current wholesale acquisition cost plus 5% for the returned product. Important: Please continue to distribute any Pulmozyme with lots not contained on Attachment #1

4) When dispensing Pulmozyme, please continue to instruct patients to follow the steps outlined in the initial correspondence, to insure that the ampules are not compromised.

  • Visually inspect all of the ampules to determine whether the appropriate levels of liquid are in the ampules. If any ampule appears to be only partially full they should be returned.
  • Even if the ampules appear full, please have them test for leaks by gently applying pressure to each ampule. If there appears to be a leak, set aside and return.

Please note that Genentech will be revising our package insert to instruct patients to always inspect ampules prior to administering Pulmozyme.

Genentech is fully committed to its customers and will continue to provide Pulmozyme. For further clarification, please feel free to contact Genentech Customer Service at (800) 551-2231 or your local Genentech Sales Representative.

Notice of this product warning was sent via email to SafeMail subscribers April 21, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.